Is Welcure Drugs And Pharmaceutic a good stock to invest in?

Welcure Drugs And Pharmaceutic can be analyzed on the following key metrics - TTM P/E: 8.38 Sector P/E: 26.62 Dividend Yield: 0% D/E ratio: -

Welcure Drugs And Pharmaceutic Share Price

Sector: Major Drugs

Powered by

8.71 +0.41 (4.94%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 8.01

Today’s High 8.71

52 Week Low 4.30

52 Week High 15.81

Key Metrics

Market Cap (In Cr) 98
Beta 0.69
Div. Yield (%) 0
P/B 8.37
TTM P/E 8.38
Peg Ratio -
Sector P/E 26.62
Open Price 8.3
Prev Close 8.3

View All Metrics

Welcure Drugs And Pharmaceutic Analysis

Price Analysis

1 Week

-0.95%
3 Months

-14.52%
6 Month

7.93%
YTD

-28.88%
1 Year

70.43%

Risk Meter

59% Low risk
59% Moderate risk
59% Balanced Risk
59% High risk
59% Extreme risk

Welcure Drugs And Pharmaceutic Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.09

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.15

Total Operating Expense
0.27

Operating Income
-0.27

Net Income Before Taxes
-0.17

Net Income
-0.17

Diluted Normalized EPS
-0.13

Period
2023

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.01

Other Operating Expenses Total
0.11

Total Operating Expense
0.12

Operating Income
-0.12

Net Income Before Taxes
-0.05

Net Income
-0.05

Diluted Normalized EPS
0

Period
2022

Total Revenue
0.11

Selling/ General/ Admin Expenses Total
0.08

Other Operating Expenses Total
0

Total Operating Expense
0.08

Operating Income
0.02

Net Income Before Taxes
0.02

Net Income
0.02

Diluted Normalized EPS
0.02

Period
2021

Total Revenue
0.13

Selling/ General/ Admin Expenses Total
0.08

Other Operating Expenses Total
0

Total Operating Expense
0.08

Operating Income
0.05

Net Income Before Taxes
0.06

Net Income
0.06

Diluted Normalized EPS
0.05

Period
2020

Total Revenue
0.08

Selling/ General/ Admin Expenses Total
0.09

Other Operating Expenses Total
0

Total Operating Expense
0.09

Operating Income
-0.01

Net Income Before Taxes
-0.01

Net Income
-0.01

Diluted Normalized EPS
-0.01

Period
2019

Total Revenue
0.08

Selling/ General/ Admin Expenses Total
0.07

Other Operating Expenses Total
0.01

Total Operating Expense
0.08

Operating Income
0

Net Income Before Taxes
0

Net Income
0

Diluted Normalized EPS
0

Period
2018

Total Revenue
0.05

Selling/ General/ Admin Expenses Total
0.07

Other Operating Expenses Total
0

Total Operating Expense
0.07

Operating Income
-0.02

Net Income Before Taxes
-0.02

Net Income
-0.02

Diluted Normalized EPS
-0.02

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Welcure Drugs And Pharmaceutic Technical

Moving Average SMA

5 Day8.19
10 Day8.17
20 Day8.55

50 Day8.61
100 Day9.56
300 Day9.04

Welcure Drugs And Pharmaceutic Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Pharmaids Pharmaceuticals
65
0
0
87.46
31.9
226.11

Bharat Immunologica And Bio Corp
23.13
-0.29
-1.24
35.88
19
99.88

Welcure Drugs And Pharmaceutic
8.71
0.41
4.94
15.81
4.3
98

Makers Laboratories
149.9
7.8
5.49
230
114
88.5

Ind Swift
13.36
0.35
2.69
34.49
12.51
71.92

Welcure Drugs And Pharmaceutic Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

14-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results

13-Nov-24
Quarterly Results

21-Oct-24
Others

14-Aug-24
Quarterly Results

10-Jun-24
Others

30-May-24
Audited Results

28-Mar-24
Others

14-Feb-24
Quarterly Results

14-Nov-23
Quarterly Results

Meeting Date
Announced on
Purpose

24-Feb-25
23-Jan-25
POM

04-Jan-25
03-Dec-24
POM

30-Sept-24
09-Sept-24
AGM

13-Jul-24
11-Jun-24
POM

28-Sept-23
20-Sept-23
AGM

27-Jun-22
26-May-22
AGM

12-Jul-21
26-May-21
AGM

View All

Company Profile

ABOUT Welcure Drugs And Pharmaceutic

Industry Major Drugs
ISIN INE331C01017
BSE Code 524661

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company operates in one segment, which is the Manufacturing of Steel, Non-Alloys Steel and Alloys Steel Casting.

MANAGEMENT

Altaf Shah Chief Financial Officer, Managing Director

WELCURE DRUGS AND PHARMACEUTIC SUMMARY

Welcure Drugs And Pharmaceutic is trading 4.94% upper at Rs 8.71 as compared to its last closing price. Welcure Drugs And Pharmaceutic has been trading in the price range of 8.71 & 8.01. Welcure Drugs And Pharmaceutic has given -28.88% in this year & -0.95% in the last 5 days.

Welcure Drugs And Pharmaceutic has TTM P/E ratio 8.38 as compared to the sector P/E of 26.62.

The company posted a net profit of 0.41 Crores in its last quarter.

Listed peers of Welcure Drugs And Pharmaceutic include Pharmaids Pharmaceuticals (0%), Bharat Immunologica And Bio Corp (-1.24%), Welcure Drugs And Pharmaceutic (4.94%) etc.

Welcure Drugs And Pharmaceutic has a 100% public holding.

FAQs about Welcure Drugs And Pharmaceutic

Welcure Drugs And Pharmaceutic is trading at 8.71 as on 28 Apr, 2025 3:22:51 PM. This is 4.94% upper as compared to its previous closing price of 8.3

The market capitalization of Welcure Drugs And Pharmaceutic is 98 Cr as on 28 Apr, 2025 3:22:51 PM.

The 52 wk high for Welcure Drugs And Pharmaceutic is 15.81 whereas the 52 wk low is 4.30

Welcure Drugs And Pharmaceutic can be analyzed on the following key metrics -

TTM P/E: 8.38
Sector P/E: 26.62
Dividend Yield: 0%
D/E ratio: -

Welcure Drugs And Pharmaceutic reported a net profit of -0.17 Cr in 2024.

Welcure Drugs And Pharmaceutic Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Welcure Drugs And Pharmaceutic Share Price

Price Range

Key Metrics

Welcure Drugs And Pharmaceutic Analysis

Welcure Drugs And Pharmaceutic Financials

Forecast

Forecast

Forecast

Welcure Drugs And Pharmaceutic Technical

Welcure Drugs And Pharmaceutic Peers

Welcure Drugs And Pharmaceutic Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Welcure Drugs And Pharmaceutic

MANAGEMENT

WELCURE DRUGS AND PHARMACEUTIC SUMMARY

FAQs about Welcure Drugs And Pharmaceutic

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue